American Society of Hirudotherapy

Highly sensitive potentiometric strip test for detecting high charge density impurities in heparin

Research article published in Analytical chemistry (2011)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportGenomics & ProteomicsKang Y et al. · Analytical chemistry, 2011

Abstract

Contamination of heparin with oversulfated chondroitin sulfate (OSCS) became a matter of grave concern in the medical field after many fatal responses to OSCS tainted heparin products occurred during the 2007-2008 period. Even though standard lab-based analytical techniques such as nuclear magnetic resonance (NMR) and strong anion-exchange high performance liquid chromatography (SAX-HPLC) have proven useful for monitoring the OSCS content in heparin products, an easy-to-use, quick, portable, and cost-efficient method is still needed for on-site monitoring during and after the heparin production. In this report, a disposable strip-type electrochemical polyion sensor is described for detection of low levels of OSCS contamination in heparin. A magnetic actuator is incorporated into this simple electrode-based microfluidic device in order to create the mixing effect necessary to achieve equilibrium potential changes of the sensor within a microfluidic channel. The planar membrane electrode detector within the sample channel is prepared with a tridodecylmethylammonium chloride (TDMAC)-doped poly(vinyl chloride) (PVC) membrane essentially equivalent to previously reported polyanion-sensitive electrodes. When the concentration of heparin applied to the single-use strip device is 57 mg/mL (in only 20 μL of sample), the same concentration recommended in the NMR analysis protocol for detecting OSCS in heparin, the detection limit is 0.005 wt % of OSCS, which is ca. 20 times lower than the reported detection limit of the NMR method.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
Indexed MeSH termsChondroitin SulfatesElectrochemical TechniquesElectrodesHeparinMagneticsMicrofluidic Analytical TechniquesPolyelectrolytesPolymersPolyvinyl ChlorideQuaternary Ammonium Compounds

Summary

Contamination of heparin with oversulfated chondroitin sulfate (OSCS) became a matter of grave concern in the medical field after many fatal responses to OSCS tainted heparin products occurred during the 2007-2008 period.

Why This Matters for Hirudotherapy

This methodological study details the development of a disposable, potentiometric strip test for detecting oversulfated chondroitin sulfate (OSCS) impurities in heparin products. The device utilizes an electrochemical polyion sensor within a microfluidic channel to achieve highly sensitive, on-site monitoring of heparin contamination. This research is focused exclusively on improving the safety and quality control of pharmaceutical heparin. Consequently, it holds no relevance to the American Society of Hirudotherapy, as the study does not involve leeches, hirudotherapy, or leech-derived anticoagulants. There is no mention of the leech secretome or any comparative analysis with hirudin, making any connection to clinical leech applications entirely absent from the abstract.

Citation

Highly sensitive potentiometric strip test for detecting high charge density impurities in heparin

Kang Y et al. · Analytical chemistry, 2011

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.